Title:
ANTI-CTLA4 ANTIBODIES
Document Type and Number:
WIPO Patent Application WO/2018/035710
Kind Code:
A1
Abstract:
The present invention discloses an anti-CTLA4 antibody, pharmaceutical composition and use thereof. The anti-CTLA4 antibody of the present invention can specifically bind CTLA4, and can effectively block the binding of CLTA4 to B7.
More Like This:
| WO/1998/033818 | HUMAN ANION CHANNEL |
| WO/2020/109542 | TREATMENT OF ACUTE GVHD USING DONOR-SPECIFIC ANTI-HLA ANTIBODIES |
| JP2023502725 | Antibodies against TIE-2 and directions for use |
Inventors:
LI BAIYONG (CN)
XIA YU (CN)
WANG ZHONGMIN (CN)
ZHANG PENG (CN)
PANG XINGHUA (CN)
XIA YU (CN)
WANG ZHONGMIN (CN)
ZHANG PENG (CN)
PANG XINGHUA (CN)
Application Number:
PCT/CN2016/096357
Publication Date:
March 01, 2018
Filing Date:
August 23, 2016
Export Citation:
Assignee:
AKESO BIOPHARMA INC (CN)
International Classes:
C07K16/28; A61K39/395; A61P35/00
Domestic Patent References:
| WO2001014424A2 | 2001-03-01 | |||
| WO2012120125A1 | 2012-09-13 |
Foreign References:
| CN105296433A | 2016-02-03 |
Attorney, Agent or Firm:
WU, FENG & ZHANG (CN)
Download PDF:
Previous Patent: BLUETOOTH PAIRING METHOD AND BLUETOOTH DEVICE
Next Patent: TARGET DETECTION METHOD AND SYSTEM
Next Patent: TARGET DETECTION METHOD AND SYSTEM